Direct and indirect pathways of basal ganglia: A critical reappraisal

Nature Neuroscience

Volumn 17, Issue 8, 2014, Pages 1022-1030

  Calabresi, Paolo ^a,b   Picconi, Barbara ^b   Tozzi, Alessandro ^a,b   Ghiglieri, Veronica ^b   Di Filippo, Massimiliano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; DOPAMINE RECEPTOR; ENDOCANNABINOID;

BACTERIAL ARTIFICIAL CHROMOSOME; BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; CORPUS STRIATUM; DIRECT PATHWAY; ENTOPEDUNCULAR NUCLEUS; GLOBUS PALLIDUS; HUMAN; INDIRECT PATHWAY; INTERNEURON; INTRACELLULAR SIGNALING; LOCOMOTION; MEDIUM SPINY NEURON; MOLECULAR INTERACTION; MOTOR CORTEX; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; OPTOGENETICS; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; BASAL GANGLIA; HUMANS; MODELS, NEUROLOGICAL; MOVEMENT; NEURAL PATHWAYS; NEURONS;

EID: 84904961722     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3743     Document Type: Review

References (100)

1. Seneca, L.A. Moral letters to Lucilius (Epistulae morales ad Lucilium): A Loeb Classical Library edition, Vol. 1 (ed. Gummere, R.M.) (W. Heinemann, 1917
2. DiFiglia, M., Pasik, P.&Pasik, T. A Golgi study of neuronal types in the neostriatum of monkeys. Brain Res. 114, 245-256 (1976
3. Dubé, L., Smith, A.D.&Bolam, J.P. Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum. J. Comp. Neurol. 267, 455-471 (1988
4. Lapper, S.R.&Bolam, J.P. Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience 51, 533-545 (1992
5. Pickel, V.M., Chan, J.&Sesack, S.R. Cellular basis for interactions between catecholaminergic afferents and neurons containing Leu-enkephalin-like immunoreactivity in rat caudate-putamen nuclei. J. Neurosci. Res. 31, 212-230 (1992
6. Bouyer, J.J., Park, D.H., Joh, T.H.&Pickel, V.M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302, 267-275 (1984
7. Kawaguchi, Y., Wilson, C.J., Augood, S.J.&Emson, P.C. Striatal interneurones: Chemical, physiological and morphological characterization. Trends Neurosci. 18, 527-535 (1995
8. Albin, R.L., Young, A.B.&Penney, J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375 (1989
9. DeLong, M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285 (1990
10. Gerfen, C.R. et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432 (1990
11. Gerfen, C.R.&Surmeier, D.J. Modulation of striatal projection systems by dopamine. Annu. Rev. Neurosci. 34, 441-466 (2011
12. Bateup, H.S. et al. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc. Natl. Acad. Sci. USA 107, 14845-14850 (2010
13. Valjent, E., Bertran-Gonzalez, J., Herve, D., Fisone, G.&Girault, J.A. Looking BAC at striatal signaling: Cell-specific analysis in new transgenic mice. Trends Neurosci. 32, 538-547 (2009
14. Kawaguchi, Y., Wilson, C.J.&Emson, P.C. Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J. Neurophysiol. 62, 1052-1068 (1989
15. Cepeda, C. et al. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons. Eur. J. Neurosci. 27, 671-682 (2008
16. Kreitzer, A.C.&Malenka, R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445, 643-647 (2007
17. Day, M., Wokosin, D., Plotkin, J.L., Tian, X.&Surmeier, D.J. Differential excitability and modulation of striatal medium spiny neuron dendrites. J. Neurosci. 28, 11603-11614 (2008
18. Gertler, T.S., Chan, C.S.&Surmeier, D.J. Dichotomous anatomical properties of adult striatal medium spiny neurons. J. Neurosci. 28, 10814-10824 (2008
19. Day, M. et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 9, 251-259 (2006
20. Calabresi, P. et al. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J. Neurosci. 20, 8443-8451 (2000
21. Calabresi, P., Maj, R., Mercuri, N.B.&Bernardi, G. Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum. Neurosci. Lett. 142, 95-99 (1992
22. Calabresi, P., Maj, R., Pisani, A., Mercuri, N.B.&Bernardi, G. Long-term synaptic depression in the striatum: Physiological and pharmacological characterization. J. Neurosci. 12, 4224-4233 (1992
23. Lovinger, D.M., Tyler, E.C.&Merritt, A. Short- and long-term synaptic depression in rat neostriatum. J. Neurophysiol. 70, 1937-1949 (1993
24. Shen, W., Flajolet, M., Greengard, P.&Surmeier, D.J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321, 848-851 (2008
25. Kravitz, A.V. et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622-626 (2010
26. Hikosaka, O., Nakamura, K.&Nakahara, H. Basal ganglia orient eyes to reward. J. Neurophysiol. 95, 567-584 (2006
27. Redgrave, P. et al. Goal-directed and habitual control in the basal ganglia: Implications for Parkinson?s disease. Nat. Rev. Neurosci. 11, 760-772 (2010
28. Tai, L.H., Lee, A.M., Benavidez, N., Bonci, A.&Wilbrecht, L. Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value. Nat. Neurosci. 15, 1281-1289 (2012
29. Eshel, N.&Roiser, J.P. Reward and punishment processing in depression. Biol. Psychiatry 68, 118-124 (2010
30. Koob, G.F.&Volkow, N.D. Neurocircuitry of addiction. Neuropsychopharmacology 35, 217-238 (2010
31. Kravitz, A.V., Tye, L.D.&Kreitzer, A.C. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat. Neurosci. 15, 816-818 (2012
32. Hikida, T., Kimura, K., Wada, N., Funabiki, K.&Nakanishi, S. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66, 896-907 (2010
33. Ferguson, S.M. et al. Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization. Nat. Neurosci. 14, 22-24 (2011
34. Voon, V. et al. Chronic dopaminergic stimulation in Parkinson?s disease: From dyskinesias to impulse control disorders. Lancet Neurol. 8, 1140-1149 (2009
35. Vitek, J.L. et al. Randomized trial of pallidotomy versus medical therapy for Parkinson?s disease. Ann. Neurol. 53, 558-569 (2003
36. Alvarez, L. et al. Bilateral subthalamotomy in Parkinson?s disease: Initial and long-term response. Brain 128, 570-583 (2005
37. Fasano, A., Daniele, A.&Albanese, A. Treatment of motor and non-motor features of Parkinson?s disease with deep brain stimulation. Lancet Neurol. 11, 429-442 (2012
38. Odekerken, V.J. et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson?s disease (NSTAPS study): A randomized controlled trial. Lancet Neurol. 12, 37-44 (2013
39. Schuepbach, W.M. et al. Neurostimulation for Parkinson?s disease with early motor complications. N. Engl. J. Med. 368, 610-622 (2013
40. Krack, P., Hariz, M.I., Baunez, C., Guridi, J.&Obeso, J.A. Deep brain stimulation: From neurology to psychiatry? Trends Neurosci. 33, 474-484 (2010
41. Vonsattel, J.P. et al. Neuropathological classification of Huntington?s disease. J. Neuropathol. Exp. Neurol. 44, 559-577 (1985
42. André, V.M. et al. Differential electrophysiological changes in striatal output neurons in Huntington?s disease. J. Neurosci. 31, 1170-1182 (2011
43. Freeze, B.S., Kravitz, A.V., Hammack, N., Berke, J.D.&Kreitzer, A.C. Control of basal ganglia output by direct and indirect pathway projection neurons. J. Neurosci. 33, 18531-18539 (2013
44. Cui, G. et al. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 494, 238-242 (2013
45. Durieux, P.F. et al. D2R striatopallidal neurons inhibit both locomotor and drug reward processes. Nat. Neurosci. 12, 393-395 (2009
46. Kress, G.J. et al. Convergent cortical innervation of striatal projection neurons. Nat. Neurosci. 16, 665-667 (2013
47. Kramer, P.F. et al. Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. J. Neurosci. 31, 126-132 (2011
48. Bagetta, V. et al. Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: Implications for Parkinson?s disease. J. Neurosci. 31, 12513-12522 (2011
49. Deng, Y.P., Lei, W.L.&Reiner, A. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J. Chem. Neuroanat. 32, 101-116 (2006
50. Chan, C.S. et al. Strain-specific regulation of striatal phenotype in Drd2-eGFP BAC transgenic mice. J. Neurosci. 32, 9124-9132 (2012
51. Nelson, A.B. et al. A comparison of striatal-dependent behaviors in wild-type and hemizygous Drd1a and Drd2 BAC transgenic mice. J. Neurosci. 32, 9119-9123 (2012
52. Cazorla, M. et al. Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron 81, 153-164 (2014
53. Kawaguchi, Y., Wilson, C.J.&Emson, P.C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10, 3421-3438 (1990
54. Lévesque, M.&Parent, A. The striatofugal fiber system in primates: A reevaluation of its organization based on single-Axon tracing studies. Proc. Natl. Acad. Sci. USA 102, 11888-11893 (2005
55. Parent, A., Charara, A.&Pinault, D. Single striatofugal axons arborizing in both pallidal segments and in the substantia nigra in primates. Brain Res. 698, 280-284 (1995
56. Nadjar, A. et al. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: A call for a reappraisal of the functional organization of the basal ganglia. J. Neurosci. 26, 8653-8661 (2006
57. Hasbi, A. et al. Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc. Natl. Acad. Sci. USA 106, 21377-21382 (2009
58. Perreault, M.L., Hasbi, A., O'Dowd, B.F.&George, S.R. Heteromeric dopamine receptor signaling complexes: Emerging neurobiology and disease relevance. Neuropsychopharmacology 39, 156-168 (2013
59. Calabresi, P., Picconi, B., Tozzi, A.&Di Filippo, M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 30, 211-219 (2007
60. Jia, Y., Gall, C.M.&Lynch, G. Presynaptic BDNF promotes postsynaptic long-term potentiation in the dorsal striatum. J. Neurosci. 30, 14440-14445 (2010
61. Lovinger, D.M. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 58, 951-961 (2010
62. Calabresi, P., Di Filippo, M., Ghiglieri, V., Tambasco, N.&Picconi, B. Levodopa-induced dyskinesias in patients with Parkinson?s disease: Filling the bench-to-bedside gap. Lancet Neurol. 9, 1106-1117 (2010
63. Russo, S.J., Mazei-Robison, M.S., Ables, J.L.&Nestler, E.J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56 (suppl. 1) 73-82 (2009
64. Adermark, L., Talani, G.&Lovinger, D.M. Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur. J. Neurosci. 29, 32-41 (2009
65. Gerdeman, G.L., Ronesi, J.&Lovinger, D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5, 446-451 (2002
66. Mathur, B.N.&Lovinger, D.M. Endocannabinoid-dopamine interactions in striatal synaptic plasticity. Front Pharmacol 3, 66 (2012
67. Adermark, L.&Lovinger, D.M. Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step. Proc. Natl. Acad. Sci. USA 104, 20564-20569 (2007
68. Yin, H.H.&Lovinger, D.M. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc. Natl. Acad. Sci. USA 103, 8251-8256 (2006
69. Ronesi, J., Gerdeman, G.L.&Lovinger, D.M. Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J. Neurosci. 24, 1673-1679 (2004
70. Wang, Z. et al. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50, 443-452 (2006
71. Tozzi, A. et al. The distinct role of medium spiny neurons and cholinergic interneurons in the D2/A2A receptor interaction in the striatum: Implications for Parkinson?s disease. J. Neurosci. 31, 1850-1862 (2011
72. Di Filippo, M. et al. The endocannabinoid system in Parkinson?s disease. Curr. Pharm. Des. 14, 2337-2347 (2008
73. Pisani, V. et al. Homeostatic changes of the endocannabinoid system in Parkinson?s disease. Mov. Disord. 26, 216-222 (2011
74. Gubellini, P. et al. Experimental parkinsonism alters endocannabinoid degradation: Implications for striatal glutamatergic transmission. J. Neurosci. 22, 6900-6907 (2002
75. Maccarrone, M. et al. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. J. Neurochem. 85, 1018-1025 (2003
76. Gerdeman, G.L., Partridge, J.G., Lupica, C.R.&Lovinger, D.M. It could be habit forming: Drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 26, 184-192 (2003
77. Nazzaro, C. et al. SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat. Neurosci. 15, 284-293 (2012
78. Vincent, S.R. Nitric oxide neurons and neurotransmission. Prog. Neurobiol. 90, 246-255 (2010
79. Fino, E.&Venance, L. Spike-timing dependent plasticity in striatal interneurons. Neuropharmacology 60, 780-788 (2011
80. West, A.R.&Tseng, K.Y. Nitric oxide-soluble guanylyl cyclase-cyclic GMP signaling in the striatum: New targets for the treatment of Parkinson?s disease? Front. Syst. Neurosci. 5, 55 (2011
81. Calabresi, P. et al. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J. Neurosci. 19, 2489-2499 (1999
82. Picconi, B. et al. Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 134, 375-387 (2011
83. Arcangeli, S. et al. Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. J. Cereb. Blood Flow Metab. 33, 278-286 (2013
84. Aziz, T.Z., Peggs, D., Sambrook, M.A.&Crossman, A.R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov. Disord. 6, 288-292 (1991
85. Bergman, H., Wichmann, T.&DeLong, M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436-1438 (1990
86. Lang, A.E. et al. Posteroventral medial pallidotomy in advanced Parkinson?s disease. N. Engl. J. Med. 337, 1036-1042 (1997
87. Levy, R. et al. Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson?s disease. J. Neurophysiol. 86, 249-260 (2001
88. Lewitt, P.A. Levodopa for the treatment of Parkinson?s disease. N. Engl. J. Med. 359, 2468-2476 (2008
89. Jenner, P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat. Rev. Neurosci. 9, 665-677 (2008
90. Mercuri, N.B.&Bernardi, G. The ?magic? of L-dopa: Why is it the gold standard Parkinson?s disease therapy? Trends Pharmacol. Sci. 26, 341-344 (2005
91. Perez-Lloret, S.&Rascol, O. Dopamine receptor agonists for the treatment of early or advanced Parkinson?s disease. CNS Drugs 24, 941-968 (2010
92. Bagetta, V. et al. Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson?s disease. J. Neurosci. 32, 17921-17931 (2012
93. Connolly, B.S.&Fox, S.H. Drug treatments for the neuropsychiatric complications of Parkinson?s disease. Expert Rev. Neurother. 12, 1439-1449 (2012
94. Toy, W.A. et al. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine (MPTP) mouse model of Parkinson?s disease. Neurobiol. Dis. 63, 201-209 (2014
95. Costa, R.M. et al. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron 52, 359-369 (2006
96. Hammond, C., Bergman, H.&Brown, P. Pathological synchronization in Parkinson?s disease: Networks, models and treatments. Trends Neurosci. 30, 357-364 (2007
97. Kasanetz, F., Riquelme, L.A., Della-Maggiore, V., O'Donnell, P.&Murer, M.G. Functional integration across a gradient of corticostriatal channels controls UP state transitions in the dorsal striatum. Proc. Natl. Acad. Sci. USA 105, 8124-8129 (2008
98. Zold, C.L., Escande, M.V., Pomata, P.E., Riquelme, L.A.&Murer, M.G. Striatal NMDA receptors gate cortico-Pallidal synchronization in a rat model of Parkinson?s disease. Neurobiol. Dis. 47, 38-48 (2012
99. Jin, X.&Costa, R.M. Start/stop signals emerge in nigrostriatal circuits during sequence learning. Nature 466, 457-462 (2010
100. Calabresi, P.&Di Filippo, M. Neuroscience: Brain?s traffic lights. Nature 466, 449 (2010